{"name":"Assistance Publique Hopitaux De Marseille","slug":"assistance-publique-hopitaux-de-marseille","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-04-01","label":"biobanking Phase 3 readout (Cancer, Lung Cancer)","drug":"biobanking","drugSlug":"biobanking","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":17,"colorKey":"oncology","drugs":[{"name":"Azithromycine","genericName":"Azithromycine","slug":"azithromycine","indication":"Other","status":"marketed"},{"name":"Blood sample 5 milliliter","genericName":"Blood sample 5 milliliter","slug":"blood-sample-5-milliliter","indication":"Other","status":"phase_2"},{"name":"Gymiso®","genericName":"Gymiso®","slug":"gymiso","indication":"Medical abortion (pregnancy termination up to a specified gestational age)","status":"phase_3"},{"name":"Venipuncture","genericName":"Venipuncture","slug":"venipuncture","indication":"Other","status":"discontinued"},{"name":"trigagrelor","genericName":"trigagrelor","slug":"trigagrelor","indication":"Other","status":"phase_3"},{"name":"Administration of drug","genericName":"Administration of drug","slug":"administration-of-drug","indication":"Other","status":"phase_3"},{"name":"Analysis of plasma samples","genericName":"Analysis of plasma samples","slug":"analysis-of-plasma-samples","indication":"Other","status":"phase_2"},{"name":"Mifegyne ®","genericName":"Mifegyne ®","slug":"mifegyne","indication":"Medical abortion (termination of early pregnancy up to 49 days gestation)","status":"phase_3"},{"name":"NIMBEX","genericName":"NIMBEX","slug":"nimbex","indication":"Muscle relaxation during anesthesia for intubation and surgery","status":"marketed"},{"name":"biobanking","genericName":"biobanking","slug":"biobanking","indication":"Other","status":"phase_1"},{"name":"blood draw","genericName":"blood draw","slug":"blood-draw","indication":"Other","status":"phase_2"},{"name":"blood samples","genericName":"blood samples","slug":"blood-samples","indication":"Other","status":"marketed"},{"name":"citrate of caffeine","genericName":"citrate of caffeine","slug":"citrate-of-caffeine","indication":"Treatment of apnea of prematurity","status":"phase_3"},{"name":"durolane","genericName":"durolane","slug":"durolane","indication":"Other","status":"phase_2"},{"name":"injection of microfat and plasma rich platelet PRP","genericName":"injection of microfat and plasma rich platelet PRP","slug":"injection-of-microfat-and-plasma-rich-platelet-prp","indication":"Other","status":"phase_1"},{"name":"levels of CNI in whole blood","genericName":"levels of CNI in whole blood","slug":"levels-of-cni-in-whole-blood","indication":"Other","status":"phase_1"},{"name":"lung parenchyma sampling","genericName":"lung parenchyma sampling","slug":"lung-parenchyma-sampling","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"Blood and Marrow sample","genericName":"Blood and Marrow sample","slug":"blood-and-marrow-sample","indication":"Acute Myeloid Leukemia","status":"phase_2"},{"name":"Durvalumab (MEDI4736)","genericName":"Durvalumab (MEDI4736)","slug":"durvalumab-medi4736","indication":"Unresectable stage III non-small cell lung cancer (NSCLC) after concurrent chemoradiotherapy","status":"phase_3"},{"name":"azacytidine","genericName":"azacytidine","slug":"azacytidine","indication":"Acute myeloid leukemia, disease","status":"marketed"},{"name":"treatment Doxorubicin","genericName":"treatment Doxorubicin","slug":"treatment-doxorubicin","indication":"Breast cancer","status":"phase_3"},{"name":"treatment Vincristin","genericName":"treatment Vincristin","slug":"treatment-vincristin","indication":"Acute lymphoblastic leukemia (ALL)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Aciclovir","genericName":"Aciclovir","slug":"aciclovir","indication":"Encephalitis due to Herpesvirus","status":"marketed"},{"name":"Nasal swab","genericName":"Nasal swab","slug":"nasal-swab","indication":"Detection of respiratory viral infections (e.g., SARS-CoV-2, influenza, RSV)","status":"marketed"},{"name":"Treatment BY METROMIDAZOLE","genericName":"Treatment BY METROMIDAZOLE","slug":"treatment-by-metromidazole","indication":"Amoebiasis","status":"phase_3"},{"name":"Treatment with Amikacin","genericName":"Treatment with Amikacin","slug":"treatment-with-amikacin","indication":"Serious gram-negative bacterial infections","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"rare","drugs":[{"name":"butyrate enemas + routine management","genericName":"butyrate enemas + routine management","slug":"butyrate-enemas-routine-management","indication":"Ulcerative colitis (adjunctive therapy with routine management)","status":"phase_3"},{"name":"etanercept Treatment","genericName":"etanercept Treatment","slug":"etanercept-treatment","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"mycophenolate mofetil or azathioprine","genericName":"mycophenolate mofetil or azathioprine","slug":"mycophenolate-mofetil-or-azathioprine","indication":"Prevention of organ rejection in patients with kidney, liver, or heart transplants","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"BYETTA treatment","genericName":"BYETTA treatment","slug":"byetta-treatment","indication":"Type 2 diabetes mellitus","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Exposure to Triptan","genericName":"Exposure to Triptan","slug":"exposure-to-triptan","indication":"Acute treatment of migraine attacks with or without aura","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Vasopressin administration","genericName":"Vasopressin administration","slug":"vasopressin-administration","indication":"Hemorrhagic shock","status":"phase_3"}]}],"pipeline":[{"name":"Azithromycine","genericName":"Azithromycine","slug":"azithromycine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Blood and Marrow sample","genericName":"Blood and Marrow sample","slug":"blood-and-marrow-sample","phase":"phase_2","mechanism":"This drug targets the bone marrow and blood to treat various conditions.","indications":["Acute Myeloid Leukemia","Chronic Lymphocytic Leukemia","Multiple Myeloma"],"catalyst":""},{"name":"Blood sample 5 milliliter","genericName":"Blood sample 5 milliliter","slug":"blood-sample-5-milliliter","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Gymiso®","genericName":"Gymiso®","slug":"gymiso","phase":"phase_3","mechanism":"Gymiso is a mifepristone-based medication that acts as a progesterone receptor antagonist to induce medical abortion.","indications":["Medical abortion (pregnancy termination up to a specified gestational age)"],"catalyst":""},{"name":"Venipuncture","genericName":"Venipuncture","slug":"venipuncture","phase":"discontinued","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"trigagrelor","genericName":"trigagrelor","slug":"trigagrelor","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aciclovir","genericName":"Aciclovir","slug":"aciclovir","phase":"marketed","mechanism":"Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase","indications":["Encephalitis due to Herpesvirus","Genital herpes simplex","Herpes labialis","Herpes simplex","Herpes simplex infection of skin"],"catalyst":""},{"name":"Administration of drug","genericName":"Administration of drug","slug":"administration-of-drug","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Analysis of plasma samples","genericName":"Analysis of plasma samples","slug":"analysis-of-plasma-samples","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"BYETTA treatment","genericName":"BYETTA treatment","slug":"byetta-treatment","phase":"phase_3","mechanism":"Byetta (exenatide) is a GLP-1 receptor agonist that mimics glucagon-like peptide-1 to stimulate insulin secretion in response to elevated blood glucose levels.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Durvalumab (MEDI4736)","genericName":"Durvalumab (MEDI4736)","slug":"durvalumab-medi4736","phase":"phase_3","mechanism":"Durvalumab is a monoclonal antibody that blocks PD-L1, preventing tumor cells from evading immune attack and allowing T cells to recognize and kill cancer cells.","indications":["Unresectable stage III non-small cell lung cancer (NSCLC) after concurrent chemoradiotherapy","Metastatic or locally advanced urothelial carcinoma","Biliary tract cancer","Gastric or gastroesophageal junction adenocarcinoma"],"catalyst":""},{"name":"Exposure to Triptan","genericName":"Exposure to Triptan","slug":"exposure-to-triptan","phase":"phase_2","mechanism":"Triptans are a class of drugs that work by stimulating serotonin receptors in the brain, leading to the dilation of blood vessels and the relief of migraine symptoms.","indications":["Acute treatment of migraine attacks with or without aura","Cluster headache"],"catalyst":""},{"name":"Mifegyne ®","genericName":"Mifegyne ®","slug":"mifegyne","phase":"phase_3","mechanism":"Mifepristone is a progesterone receptor antagonist that blocks progesterone signaling to induce abortion or manage progesterone-dependent conditions.","indications":["Medical abortion (termination of early pregnancy up to 49 days gestation)","Cushing's syndrome (progesterone-dependent conditions)"],"catalyst":""},{"name":"NIMBEX","genericName":"NIMBEX","slug":"nimbex","phase":"marketed","mechanism":"Nimbex (cisatracurium) is a non-depolarizing neuromuscular blocking agent that competitively inhibits acetylcholine at the neuromuscular junction.","indications":["Muscle relaxation during anesthesia for intubation and surgery","Facilitation of mechanical ventilation in intensive care units"],"catalyst":""},{"name":"Nasal swab","genericName":"Nasal swab","slug":"nasal-swab","phase":"marketed","mechanism":"A nasal swab is a diagnostic collection device used to obtain respiratory samples for laboratory testing.","indications":["Detection of respiratory viral infections (e.g., SARS-CoV-2, influenza, RSV)","Bacterial respiratory infection screening","General respiratory pathogen surveillance"],"catalyst":""},{"name":"Treatment BY METROMIDAZOLE","genericName":"Treatment BY METROMIDAZOLE","slug":"treatment-by-metromidazole","phase":"phase_3","mechanism":"Metronidazole is an antibiotic that works by stopping the growth of bacteria and protozoa.","indications":["Amoebiasis","Bacterial vaginosis","Gastrointestinal infections","Pelvic inflammatory disease","Perioperative prophylaxis"],"catalyst":""},{"name":"Treatment with Amikacin","genericName":"Treatment with Amikacin","slug":"treatment-with-amikacin","phase":"marketed","mechanism":"Amikacin is an aminoglycoside antibiotic that binds to bacterial 30S ribosomal subunits and inhibits protein synthesis, leading to bacterial cell death.","indications":["Serious gram-negative bacterial infections","Nosocomial infections caused by susceptible organisms","Septicemia","Respiratory tract infections","Urinary tract infections"],"catalyst":""},{"name":"Vasopressin administration","genericName":"Vasopressin administration","slug":"vasopressin-administration","phase":"phase_3","mechanism":"Vasopressin acts as a potent vasoconstrictor by stimulating V1A receptors on vascular smooth muscle cells, causing blood vessels to constrict.","indications":["Hemorrhagic shock","Cardiogenic shock","Severe burns"],"catalyst":""},{"name":"azacytidine","genericName":"azacytidine","slug":"azacytidine","phase":"marketed","mechanism":"DNA (cytosine-5)-methyltransferase 1, DNA (cytosine-5)-methyltransferase 3A","indications":["Acute myeloid leukemia, disease","Chronic myelomonocytic leukemia","Myelodysplastic syndrome"],"catalyst":""},{"name":"biobanking","genericName":"biobanking","slug":"biobanking","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"blood draw","genericName":"blood draw","slug":"blood-draw","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"blood samples","genericName":"blood samples","slug":"blood-samples","phase":"marketed","mechanism":"Blood samples are biological specimens collected for diagnostic testing and analysis.","indications":[],"catalyst":""},{"name":"butyrate enemas + routine management","genericName":"butyrate enemas + routine management","slug":"butyrate-enemas-routine-management","phase":"phase_3","mechanism":"Butyrate enemas deliver short-chain fatty acids directly to the colon to reduce inflammation and promote healing of the intestinal mucosa.","indications":["Ulcerative colitis (adjunctive therapy with routine management)"],"catalyst":""},{"name":"citrate of caffeine","genericName":"citrate of caffeine","slug":"citrate-of-caffeine","phase":"phase_3","mechanism":"Caffeine citrate acts as a central nervous system stimulant by inhibiting adenosine receptors.","indications":["Treatment of apnea of prematurity"],"catalyst":""},{"name":"durolane","genericName":"durolane","slug":"durolane","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"etanercept Treatment","genericName":"etanercept Treatment","slug":"etanercept-treatment","phase":"phase_3","mechanism":"Etanercept is a tumor necrosis factor-alpha (TNF-alpha) inhibitor that works by binding to TNF-alpha and preventing it from interacting with its receptors on cell surfaces.","indications":["Rheumatoid arthritis","Juvenile idiopathic arthritis","Psoriatic arthritis","Plaque psoriasis"],"catalyst":""},{"name":"injection of microfat and plasma rich platelet PRP","genericName":"injection of microfat and plasma rich platelet PRP","slug":"injection-of-microfat-and-plasma-rich-platelet-prp","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"levels of CNI in whole blood","genericName":"levels of CNI in whole blood","slug":"levels-of-cni-in-whole-blood","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"lung parenchyma sampling","genericName":"lung parenchyma sampling","slug":"lung-parenchyma-sampling","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"mycophenolate mofetil or azathioprine","genericName":"mycophenolate mofetil or azathioprine","slug":"mycophenolate-mofetil-or-azathioprine","phase":"phase_3","mechanism":"Mycophenolate mofetil and azathioprine are immunosuppressive drugs that inhibit the enzyme inosine monophosphate dehydrogenase (IMPDH), which is necessary for the proliferation of T and B lymphocytes.","indications":["Prevention of organ rejection in patients with kidney, liver, or heart transplants","Treatment of certain autoimmune diseases, such as lupus nephritis and myasthenia gravis"],"catalyst":""},{"name":"treatment Doxorubicin","genericName":"treatment Doxorubicin","slug":"treatment-doxorubicin","phase":"phase_3","mechanism":"Doxorubicin intercalates into DNA and inhibits topoisomerase II, preventing DNA replication and transcription in cancer cells.","indications":["Breast cancer","Lymphomas","Leukemias","Sarcomas","Ovarian cancer"],"catalyst":""},{"name":"treatment Vincristin","genericName":"treatment Vincristin","slug":"treatment-vincristin","phase":"phase_3","mechanism":"Vincristine is a vinca alkaloid that binds to tubulin and disrupts microtubule formation, causing cell cycle arrest in metaphase and triggering apoptosis in cancer cells.","indications":["Acute lymphoblastic leukemia (ALL)","Hodgkin lymphoma","Non-Hodgkin lymphoma","Small cell lung cancer","Breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZDlxM29BMGNsMXZnLUhYcHhRRklSems4dG1nQjdZUm1WNXgxd3NVSW1qM0FHUWhuYk5QWTZWOFdteGNtNEZRM0RWOW5qOEJiNW0wS2FpOU9EaThCZ3RRZ1dIYW0tS1pZX1o1MUZBNlFUV2tJbm5PbXZxa1c0MlZYUVJNODJMNk9YLTRNckdocXVvbUFZSUM3ekY0Q2t0RXlWNXNmRzl4YWNDLVZCWUFvdkpIZjZjeVc2NUN2QkZaSVQ?oc=5","date":"2024-09-06","type":"pipeline","source":"Le Point","summary":"EXCLUSIVE: IHU and Marseille Hospitals Issue Warning Against Pr. Raoul - Le Point","headline":"EXCLUSIVE: IHU and Marseille Hospitals Issue Warning Against Pr. Raoul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBQV2RCWTNYODdrTHFZV3VnRnNjOWJQVElIUGI4QWZMdXBWMU1rbG9FTmV2eGJBTzVnTHp6OTB1RjVIb0VMU1lOcnVSTHJ2UHhYU1F0dUxvZzJGRXNRWHNESnBNeXExNDJBUEE?oc=5","date":"2023-09-10","type":"pipeline","source":"Wiley Online Library","summary":"Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients - Wiley Online Library","headline":"Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPX3FVRjBZeHlsMlhmeTBwVVh2T0xxaHZINEdvaFRRQUs3Yld5a2ZuSnIxY0tsZTNoeDVMRGpHLV9tYVhOTGxZV05OTlZBbU9HX01ROFVUeEFEU01DLUtrb2FFMWxJOVZvSE9XUGxaNjUycHFwOVlGQk5zN3o0elVzdVVWc0g4Mm9mWW8xbzdoaGx2bzN1cGNVT20wUS1BMUxsMXFtUWpWQURrdw?oc=5","date":"2022-09-06","type":"pipeline","source":"Rockefeller University Press","summary":"Bringing natural killer cells to the clinic - Rockefeller University Press","headline":"Bringing natural killer cells to the clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1rTFFVQlBZUTE5akxGa3NMVTBIbG1Zdm5DcDg1R3JaWTd3M0ZOV09IU3A5Nm9qSVJiZ2xhc3A2X25Xc05RUjA1LTNENmtKSGJuYUY0VkN5eFIxeklaMVE?oc=5","date":"2020-07-29","type":"pipeline","source":"Nature","summary":"Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis - Nature","headline":"Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBWaS1hQWJWU1JyR0xMZ3BUMnRwajl6VDVOM2VDS2tNOFNSWDE3cG9YRjVOMndITTRXUHEzdjdTeE9OQmVTUkF3NUJxaGs2S2laUjlfNThRUDNsbUZjdjIw?oc=5","date":"2020-02-26","type":"pipeline","source":"Nature","summary":"ILC development and protection from intestinal inflammation in mice - Nature","headline":"ILC development and protection from intestinal inflammation in mice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5NS2Q3OE1xWGdHelZlaTQzQmd5d0c3WjcxRnA3SnJ0c0Q1RjcxNTFObzc5aWg4ZXZQdHBDaDZUeDhzRndUTVBNcnpBUG9qUldYTlRV?oc=5","date":"2017-03-23","type":"pipeline","source":"Nature","summary":"Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression - Nature","headline":"Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression","sentiment":"neutral"}],"patents":[],"drugCount":32,"phaseCounts":{"marketed":7,"phase_2":7,"phase_3":14,"discontinued":1,"phase_1":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}